Patents by Inventor Yael Schwartz

Yael Schwartz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ESTROGEN RECEPTOR BETA SELECTIVE LIGANDS
    Publication number: 20240294566
    Abstract: An estrogen receptor ? selective ligand can be a compound according to Structure 1: wherein m is 0, 1, or 2 and R is H, a C1 to C5 alkyl group, vinyl, CF3, CH2CH2F, CH2CHF2, or CH2CF3. A composition (e.g., pharmaceutical or cosmetic composition) can include an effective amount of a compound according to Structure 1 and a physiologically acceptable carrier, diluent, or excipient, formulated for topical administration. A method (e.g., therapeutic or cosmetic method) can include administering to a subject in need thereof an effective amount of a compound according to Structure 1 or a composition including Structure 1. Administration can be topical (e.g., to skin, scalp or mucosa).
    Type: Application
    Filed: May 3, 2024
    Publication date: September 5, 2024
    Inventors: Yael Schwartz, Craig Abolin
  • ESTROGEN RECEPTOR BETA SELECTIVE LIGANDS
    Publication number: 20200377546
    Abstract: An estrogen receptor ? selective ligand can be a compound according to Structure 1: wherein m is 0, 1, or 2 and R is H, a C1 to C5 alkyl group, vinyl, CF3, CH2CH2F, CH2CHF2, or CH2CF3. A composition (e.g., pharmaceutical or cosmetic composition) can include an effective amount of a compound according to Structure 1 and a physiologically acceptable carrier, diluent, or excipient, formulated for topical administration. A method (e.g., therapeutic or cosmetic method) can include administering to a subject in need thereof an effective amount of a compound according to Structure 1 or a composition including Structure 1. Administration can be topical (e.g., to skin, scalp or mucosa).
    Type: Application
    Filed: August 21, 2017
    Publication date: December 3, 2020
    Inventors: Yael Schwartz, Craig Abolin
  • Methods of Using Albuterol and Calcium Activated Potassium Channel Openers
    Publication number: 20090035224
    Abstract: This invention related to methods of treating, preventing and managing various pulmonary or respiratory diseases or disorders using albuterol in combination with calcium activated potassium channel openers. Pharmaceuticals compositions comprising albuterol and calcium activated potassium channel openers are also disclosed.
    Type: Application
    Filed: June 14, 2005
    Publication date: February 5, 2009
    Applicant: SEPRACOR INC.
    Inventors: Anne M. Sullivan, John W. Simon, Yael Schwartz
  • Methods and Compositions for the Treatment of Pulmonary Diseases
    Publication number: 20080293788
    Abstract: This invention related to methods of treating, preventing and managing various pulmonary diseases or disorders using formoterol in combination with calcium activated potassium channel openers. Pharmaceutical compositions comprising formoterol and calcium activated potassium channel openers are also disclosed.
    Type: Application
    Filed: June 14, 2005
    Publication date: November 27, 2008
    Inventors: Anne M. Sullivan, John W. Simon, Yael Schwartz